Public methods overview · Version 1.0

Make the evidence-to-action pathway inspectable.

P4L uses this framework to evaluate sources, bound claims, distinguish interpretation, support institutional decisions, govern public versions, disclose material relationships, and correct consequential errors.

Status: This is P4L’s public methods overview. It is not an independently issued Evidence and Trust Standard, a certification program, a clinical-evidence grade, or a substitute for scientific, clinical, legal, regulatory, or reimbursement review.
Workflow

Signal → Evidence → Decision → Adoption → Impact

SignalRecord origin, date, relevance, novelty, and what would make the development consequential.
EvidenceRetrieve authoritative sources; assess population, context, design, intended use, uncertainty, and limitations.
DecisionSeparate source facts from P4L interpretation; identify the decision, owner, options, and consequences.
AdoptionTest workflow, capability, incentives, payment, policy, trust, access, and implementation conditions.
ImpactDistinguish delivery, completion, operational, functional, clinical, economic, equity, and learning outcomes.
Controls

What public P4L work should show.

Source hierarchy

  • Primary or authoritative records for current institutional, program, regulatory, and policy status
  • Peer-reviewed human evidence and authoritative guidance for health and clinical claims
  • Secondary sources only when their added interpretation is necessary and attributable

Claim classes

  • Source fact: directly supported by the cited record
  • P4L interpretation: a bounded synthesis or implication
  • Hypothesis: a proposition requiring further evidence
  • Scenario: a conditional future possibility, not a forecast

Evidence strength

  • Established human evidence
  • Emerging human evidence with limitations
  • Mechanistic or preclinical evidence
  • Unknown, conflicting, unsupported, or overstated

Status precision

Proposed, announced, funded, selected, accepted, enrolled, authorized, cleared, launched, operational, completed, effective, and scaled are not interchangeable.

Outcome precision

A biomarker, digital signal, engagement measure, delivery event, functional outcome, clinical outcome, operational result, and economic result must not be treated as equivalents.

Context and safety

Population, setting, intended use, material limitations, uncertainty, access, equity, burden, safety, and relevant regulatory boundaries travel with the claim.

Review and versioning

Substantive artifacts should identify author, reviewer status, publication date, material update date, version, source-check date, and correction path. No reviewer is implied when none has approved the work.

Disclosure

Material financial, advisory, employment, sponsor, personal, or institutional relationships that could affect interpretation should be disclosed at the artifact level.

Generative AI

AI may assist ideation, structure, editing, metadata, source discovery, coding, and repetitive checks. It is not the authority for consequential factual, health, policy, regulatory, legal, or biographical claims; a human must verify and approve them.

Corrections

A visible pathway, not a disclaimer.

Material errors are corrected on the affected artifact with a dated note when the change affects meaning. Minor typographic or formatting repairs may be made without a correction entry when they do not alter substance.

Version1.0
Published / updatedAugust 9, 2026
Author and publisherStephen Phillips / Prevention for Longevity
Independent external reviewNone claimed for this public methods overview